Ascorbic Acid Injection
NDC Package 84897-058-25
Package Information
Ascorbic Acid injection is indicated for the short term (up to 1 week) treatment of scurvy in adult and pediatric patients, age 5 months and older, for whom oral administration is not possible, insufficient or contraindicated.Limitations of UseAscorbic Acid Injection is not indicated for the treatment of vitamin C deficiency that is not associated with signs and symptoms of scurvy. This formulation utilizes a injection delivery system. Marketed by Renova Pharmaceuticals Llc, this product is identified by NDC 84897-058 and is authorized under FDA application ANDA220172.
Identification & Billing
- RxCUI: 308395 - ascorbic acid 500 MG/ML Injectable Solution
- RxCUI: 308395 - vitamin C 500 MG/ML Injectable Solution
- RxCUI: 308395 - vit-C 500 MG/ML Injectable Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 84897 - Renova Pharmaceuticals Llc
- 84897-058 - Ascorbic Acid
- 84897-058-25 - 25 VIAL, GLASS in 1 TRAY / 50 mL in 1 VIAL, GLASS
- 84897-058 - Ascorbic Acid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (84897-058). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84897-058-25 identifies a specific commercial package of 25 vial, glass in 1 tray / 50 ml in 1 vial, glass of Ascorbic Acid, a human prescription drug labeled by Renova Pharmaceuticals Llc. This injection is formulated for intravenous use and contains ascorbic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Renova Pharmaceuticals Llc on August 08, 2026. The current certification is valid through December 31, 2027.
How is this Renova Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84897005825. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.